Gene: GNAQ
Official Full Name: G protein subunit alpha qprovided by HGNC
Gene Summary: This locus encodes a guanine nucleotide-binding protein. The encoded protein, an alpha subunit in the Gq class, couples a seven-transmembrane domain receptor to activation of phospolipase C-beta. Mutations at this locus have been associated with problems in platelet activation and aggregation. A related pseudogene exists on chromosome 2.[provided by RefSeq, Nov 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00614 | GNAQ Knockout cell line(HEK293) | Human | GNAQ | 1:3~1:6 | Negative | Online Inquiry |
KO08789 | GNAQ Knockout cell line (HeLa) | Human | GNAQ | 1:3~1:6 | Negative | Online Inquiry |
KO08790 | GNAQ Knockout cell line (HCT 116) | Human | GNAQ | 1:2~1:4 | Negative | Online Inquiry |
KO08791 | GNAQ Knockout cell line (A549) | Human | GNAQ | 1:3~1:4 | Negative | Online Inquiry |
GNAQ Gene Knockout Cell Lines are genetically engineered cellular models designed to study the functional consequences of GNAQ gene inactivation. This product provides researchers with a powerful tool to investigate the role of GNAQ, a gene implicated in several developmental and pathological processes, including uveal melanoma and other neuroectodermal tumors. The knockout mechanism is achieved through advanced CRISPR-Cas9 technology, which precisely targets and induces double-strand breaks in the GNAQ locus, leading to frameshift mutations and a complete loss of function.
The critical functions of these cell lines lie in their ability to mimic the biological effects of GNAQ loss, giving researchers insight into the downstream signaling cascades and cellular pathways affected by its absence. By utilizing these cell lines, scientists can explore GNAQ's role in cell proliferation, apoptosis, and tumor microenvironment interactions in a controlled environment, thus yielding valuable data for research and potential therapeutic interventions.
The scientific importance of GNAQ Gene Knockout Cell Lines extends into both basic and applied research, notably in cancer biology and drug discovery. These cell lines facilitate the identification of novel molecular targets, evaluation of drug efficacy, and the elucidation of resistance mechanisms in cancer treatment regimens. Compared to alternatives like wild-type cell lines or transient transfection methods, these knockout models offer a stable, reproducible, and precise approach for long-term studies, minimizing variability and enhancing the reliability of experimental outcomes.
The unique selling points of our GNAQ Gene Knockout Cell Lines are their validated performance and robustness, alongside comprehensive technical support available to all users. They empower researchers to advance their studies with confidence, knowing they are equipped with top-tier experimental models.
Our company prides itself on its expertise in genetic engineering and commitment to providing high-quality biological products that facilitate innovative research. With a focus on advancing the life sciences, we continually aim to meet the evolving needs of researchers and clinicians, ensuring they have access to the best tools for their groundbreaking work.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.